OOIR: Observatory of International Research

Papers

(The TQCC of Rheumatic Disease Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Racial/Ethnic, Socioeconomic, and Geographic Disparities in the Epidemiology of Knee and Hip Osteoarthritis	46
Risk Factors and Cancer Screening in Myositis	29
Rheumatoid Arthritis	29
Osteoarthritis Treatment Guidelines from Six Professional Societies	28
Racial/Ethnic and Socioeconomic Disparities in Osteoarthritis Management	26
Treatment Guidelines in Rheumatoid Arthritis	25
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis	24
Basic Mechanisms of Pain in Osteoarthritis	24
Gender and Ethnic Inequities in Gout Burden and Management	23
Understanding Lupus Disparities Through a Social Determinants of Health Framework	23
Cancer and Rheumatoid Arthritis	23
Axial Psoriatic Arthritis	22
Cancer and Systemic Lupus Erythematosus	22
Systemic Lupus Erythematosus Classification and Diagnosis	18
COVID-19 in Pediatrics	17
Socioeconomic Status, Health Care, and Outcomes in Systemic Lupus Erythematosus	15
Cancer and Scleroderma	15
Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries	14
Classification Criteria in Axial Spondyloarthritis	14
Health Disparities in Systemic Lupus Erythematosus	14
B Cells in Systemic Lupus Erythematosus	14
Juvenile Localized Scleroderma	13
Recent Updates in Juvenile Spondyloarthritis	13
(Health-Related) Quality of Life as an Outcome in Studies of Axial Spondyloarthritis	13
Racial Disparities in Systemic Sclerosis	13

Autoimmunity, Clonal Hematopoiesis, and Myeloid Neoplasms	13
Neutrophil Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus	13
Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus	12
Targeting Nerve Growth Factor for Pain Management in Osteoarthritis—Clinical Efficacy and Safety	12
Risk of Malignancy in Spondyloarthritis	12
Treat to Target in Axial Spondyloarthritis	11
Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus	11
Racial Disparities in Rheumatology Through the Lens of Critical Race Theory	11
Juvenile-Versus Adult-Onset Spondyloarthritis	10
The Power of Systems Biology	10
Sjögren Syndrome and Cancer	10
Pathogenesis of Axial Spondyloarthritis — Sources and Current State of Knowledge	9
Low Back Pain in Adolescent and Geriatric Populations	9
Uveitis in Children and Adolescents	9
Treatment Update in Systemic Lupus Erythematous	9
Interferons in Systemic Lupus Erythematosus	9
Disparities in Rheumatoid Arthritis Care and Health Service Solutions to Equity	9
Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes	8
The Categorization of Pain in Systemic Lupus Erythematosus	8
T Cells in Systemic Lupus Erythematosus	8
The Temporomandibular Joint in Juvenile Idiopathic Arthritis	8
Intestinal Microbiota, HLA-B27, and Spondyloarthritis	8
Mental Health in Pediatric Rheumatology	8
Environmental Triggers of Hyperuricemia and Gout	8
Recommendations for Systemic Lupus Erythematosus	8
Pain in Axial Spondyloarthritis	8
Juvenile Idiopathic Arthritis Treatment Updates	8
Systemic Autoinflammatory Diseases	7
What Does Human Leukocyte Antigen B27 Have to Do with Spondyloarthritis?	7
Pain Mechanisms in Patients with Rheumatic Diseases	7
Disparities in Childhood-Onset Lupus	7
Chronic Nonbacterial Osteomyelitis	7
Health Disparities in Rheumatic Diseases	7
Management of Pregnancy in Lupus	7
Paraneoplastic Musculoskeletal Syndromes	7
Disparities in Pediatric Rheumatic Diseases	7
Designing an Intervention to Improve Management of High-Risk Lupus Patients Through Care Coordination	7
Understanding the Disproportionate Burden of Rheumatic Diseases in Indigenous North American Populations	6
Why It Hurts	6
Emerging Imaging Techniques in Spondyloarthritis	6
Unique Aspects of Pediatric Sjögren Disease	6
Understanding Risk Factors for Poor Outcomes in a Multiethnic Longitudinal Cohort	6
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	6
Leveraging Telemedicine as an Approach to Address Rheumatic Disease Health Disparities	6
Pharmacosurveillance in Juvenile Idiopathic Arthritis	5
Behçet Syndrome	5
Fibromyalgia	5
Ultrasonography in Pediatric Rheumatology	5
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development	5
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	5

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	5
The Contribution of Genetics and Epigenetics to Our Understanding of Health Disparities in Rheumatic Diseases	5
Juvenile Fibromyalgia	5
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	5
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis	5
Sexual Dimorphism in the Expression of Pain Phenotype in Preclinical Models of Rheumatoid Arthritis	4
Environmental Risks for Spondyloarthropathies	4
Treatment Guidelines in Vasculitis	4
The Patient’s Perspective on the Burden of Disease in Ankylosing Spondylitis	4
Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials	4
The GRADE Method	4
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy	4
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	4
Axial Spondyloarthritis in the Era of Precision Medicine	4
Instrumental Substance Use Among Youth with Rheumatic Disease—A Biopsychosocial Model	4
Cardiovascular Health in Pediatric Rheumatologic Diseases	4